Floatz logo

Suvecaltamide

Tremor

Jazz PharmaceuticalsSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Tremor cohort.

Asset / SponsorPhaseRating
Istradefylline
Georgetown University
Phase 4BB
Xeomin®
Melbourne Health
Phase 3B
INCOBOTULINUMTOXINA
Yale University
Phase 2B
Bont-A
Western University, Canada
Phase 2CCC
PRILOCAINE
Western University, Canada
Phase 2CCC

View all 10 →

Same molecule, other indications

Suvecaltamide is also rated in:

Parkinson diseaseDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →